- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Amyotrophic lateral sclerosis (ALS)
- Meeting Date: November 2025
- Public Summary Document (PSD) November 2025 PBAC Meeting - (PDF 1.5MB)
- Public Summary Document (PSD) November 2025 PBAC Meeting - (Word 4.2MB)
Tofersen – November 2025
Tofersen: Solution for intrathecal injection 100 mg in 15 mL; Qalsody® - November 2025
Last updated
5 November 2025